By On March 21, 2019, the group of workers on the Penn Memory Center in Philadelphia was once scrambling to be told extra about an early-morning announcement: Two pharmaceutical firms, Biogen and Eisai, would discontinue their scientific trial of a drug supposed to sluggish the development of early Alzheimer’s illness. A
By As the coronavirus spreads, one study predicts that even the best-case scenario is 15 million dead and a $2.4 trillion hit to global GDP
Spencer Platt/Getty Images Traders paintings at the ground of the New York Stock Exchange (NYSE) on January 27, 2020, in New York City. As coronavirus circumstances proceed to upward push around the globe, mavens expect that the industry affects on of the illness – within the best-case state of affairs
By 
